Page last updated: 2024-08-24

pemirolast and Conjunctivitis, Allergic

pemirolast has been researched along with Conjunctivitis, Allergic in 9 studies

*Conjunctivitis, Allergic: Conjunctivitis due to hypersensitivity to various allergens. [MeSH]

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's6 (66.67)29.6817
2010's1 (11.11)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Shen, T; Yang, Z1
Ben-Eli, H; Solomon, A1
Abelson, MB; Amdahl, LD; Berdy, GJ; Graves, AL; Mundorf, T1
Amdahl, L; Graves, A; Shulman, DG; Washington, C1
Gous, P; Ropo, A1
Hossen, MA; Kamei, C; Minami, K1
Fujishima, H; Fukagawa, K; Fukushima, A; Miyazaki, D; Nakagawa, Y; Okamoto, S; Takamura, E; Tanaka, M; Uchio, E; Yokoi, N1
Higasida, M; Jikuhara, Y; Nakagawa, Y; Yuasa, T1

Reviews

1 review(s) available for pemirolast and Conjunctivitis, Allergic

ArticleYear
Topical antihistamines, mast cell stabilizers, and dual-action agents in ocular allergy: current trends.
    Current opinion in allergy and clinical immunology, 2018, Volume: 18, Issue:5

    Topics: Administration, Ophthalmic; Anti-Allergic Agents; Benzazepines; Conjunctivitis, Allergic; Cromolyn Sodium; Dibenzazepines; Histamine Antagonists; Humans; Hyperemia; Imidazoles; Ketotifen; Nedocromil; Olopatadine Hydrochloride; Phthalazines; Piperidines; Pruritus; Pyridines; Pyrimidinones

2018

Trials

4 trial(s) available for pemirolast and Conjunctivitis, Allergic

ArticleYear
Pemirolast potassium 0.1% ophthalmic solution is an effective treatment for allergic conjunctivitis: a pooled analysis of two prospective, randomized, double-masked, placebo-controlled, phase III studies.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2002, Volume: 18, Issue:5

    Topics: Adolescent; Adult; Aged; Child; Conjunctivitis, Allergic; Double-Blind Method; Female; Histamine Antagonists; Humans; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Pyridines; Pyrimidinones; Treatment Outcome

2002
A combined analysis of two studies assessing the ocular comfort of antiallergy ophthalmic agents.
    Clinical therapeutics, 2003, Volume: 25, Issue:4

    Topics: Administration, Topical; Adult; Anti-Allergic Agents; Conjunctivitis, Allergic; Cromolyn Sodium; Double-Blind Method; Female; Histamine Antagonists; Humans; Ketorolac; Male; Middle Aged; Nedocromil; Ophthalmic Solutions; Patient Compliance; Pyridines; Pyrimidinones; Treatment Outcome

2003
A comparative trial of the safety and efficacy of 0.1 percent pemirolast potassium ophthalmic solution dosed twice or four times a day in patients with seasonal allergic conjunctivitis.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2004, Volume: 20, Issue:2

    Topics: Adolescent; Adult; Aged; Child; Conjunctivitis, Allergic; Drug Administration Schedule; Female; Histamine Antagonists; Humans; Instillation, Drug; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Pyridines; Pyrimidinones; Seasons; Treatment Outcome

2004
The effect of a combined therapy with a histamine H1 antagonist and a chemical mediator release inhibitor on allergic conjunctivitis.
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 2008, Volume: 222, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Conjunctivitis, Allergic; Drug Therapy, Combination; Eosinophils; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Leukocyte Count; Male; Middle Aged; Ophthalmic Solutions; Piperidines; Pyridines; Pyrimidinones; Treatment Outcome

2008

Other Studies

4 other study(ies) available for pemirolast and Conjunctivitis, Allergic

ArticleYear
In vivo and in vitro Evaluation of in situ Gel Formulation of Pemirolast Potassium in Allergic Conjunctivitis.
    Drug design, development and therapy, 2021, Volume: 15

    Topics: Animals; Conjunctivitis, Allergic; Drug Compounding; Gels; Mice; Mice, Inbred BALB C; Ophthalmic Solutions; Pyridines; Pyrimidinones; Rabbits; Viscosity

2021
Increasing effect by simultaneous use of levocabastine and pemirolast on experimental allergic conjunctivitis in rats.
    Biological & pharmaceutical bulletin, 2005, Volume: 28, Issue:3

    Topics: Animals; Conjunctivitis, Allergic; Drug Synergism; Drug Therapy, Combination; Histamine Release; Male; Piperidines; Pyridines; Pyrimidinones; Rats; Rats, Wistar

2005
[Suppression of conjunctival provocation by 0.1% pemirolast potassium ophthalmic solution in VKC].
    Arerugi = [Allergy], 1994, Volume: 43, Issue:12

    Topics: Adolescent; Adult; Antigens; Conjunctiva; Conjunctivitis, Allergic; Female; Histamine Antagonists; Histamine Release; Humans; Male; Ophthalmic Solutions; Pyridines; Pyrimidinones

1994
New drugs for allergic conjunctivitis.
    The Medical letter on drugs and therapeutics, 2000, May-01, Volume: 42, Issue:1077

    Topics: Adult; Anti-Allergic Agents; Child; Child, Preschool; Clinical Trials as Topic; Conjunctivitis, Allergic; Headache; Histamine H1 Antagonists; Humans; Ketotifen; Nedocromil; Pyridines; Pyrimidinones; Rhinitis

2000